Increasing Bowel Screening Response from non-responders
Research type
Research Study
Full title
Increasing Bowel Screening Response from non-responders
IRAS ID
253013
Contact name
Paramjit Gill
Contact email
Sponsor organisation
NHS Coventry and Rugby & Warwickshire North Clinical Commissioning Groups
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Bowel cancer is a major cause of morbidity and mortality accounting for approximately 14,000 deaths in England each year. Early detection through screening increases bowel cancer survival.\nUptake of bowel screening by GP practice populations across Coventry and Warwickshire ranges from 24% to 71%, with all practices falling below the national target of 75%. As such the full potential to save lives and increase the cost-effectiveness of bowel cancer treatment is not being realised. It has also been noted that there are differences in bowel screening uptake depending on the ethnicity and socio-economic status of the population. \nThrough a combination of contacting non-responding patients through letters and/or phone calls, uptake has been shown to increase. We aim to evaluate this approach within Coventry and Warwickshire general practices by randomly allocating them to either a letter invitation or a letter and telephone.\nThis will be undertaken over 12 months and will include participants who are eligible for the national bowel cancer screening programme who are not diagnosed with previous or current cancer and who have not responded to the programme within the last 9 months.
REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
18/LO/2041
Date of REC Opinion
15 Nov 2018
REC opinion
Favourable Opinion